Khairy H Morsy et al. 2019. Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?. Turkish Journal of Gastroenterology. 27, 1 (Jul. 2019), 55–61.